Clinical trials
Terminated Gram-Positive Bacterial Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Pfizer | 2 |
| Cumberland Pharmaceuticals | 1 |
| Mannkind Corporation | 1 |
| University of Colorado, Denver | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gram-Positive Bacterial Infections | 7 |
| Bacteremia | 3 |
| Endocarditis | 2 |
| Staphylococcal Infections | 2 |
| Actinomycetales Infections | 1 |
| Bacterial Infections | 1 |
| Bacterial Infections and Mycoses | 1 |
| Bronchiectasis | 1 |
| Endocarditis, Bacterial | 1 |
| Infections | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.